M. Elisabeth· @ChildrenNeedUs_ · X·· 2026-04-21Score60
Reading
KRAS / RAS targeting: from platform to Phase 3
daraxonrasib ± GnP · mono ORR 47%; +GnP ORR 55%, DCR 90%
Body
Dr Balachandran is the lead researcher, the lead PI, of the pancreatic cancer mRNA study.
#AACR26
#AACR2026
#PancreaticCancer
Heat 0 · 0 likes · 0 replies · 0 reposts
Source: M. Elisabeth · x.com